EarningsQ2 2022 Earnings Report

Aridis Pharmaceuticals (ARDS) Q2 2022 Earnings Report

203 Followers

ARDS Q2 2022 EPS Results

Actual EPS-$0.45

Consensus EPS-$0.06

Beat/MissMissed by -$0.39

One Year Ago EPS-$0.49

Actual Revenue$292.00K

Expected Revenue$10.46M

Beat/MissMissed by -$10.17M

YoY Revenue Growth+784.85%

QuarterQ2 2022

Date08/16/2022

TimeAfter Close

Conference CallTuesday, August 16, 2022

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
May 20, 2025	2025 (Q1)	- / -	―	―
Nov 20, 2024	2024 (Q3)	- / -	0	―
Aug 13, 2024	2024 (Q2)	- / -	0.33	―
May 14, 2024	2024 (Q1)	- / -	―	―
Nov 03, 2023	2023 (Q3)	-0.10 / 0.00	-0.47	―
Aug 15, 2023	2023 (Q2)	- / -	―	―
Jun 08, 2023	2023 (Q1)	- / -0.22	-0.44	50.00% (+0.22)
Mar 30, 2023	2022 (Q4)	-0.41 / -0.40	-0.92	56.52% (+0.52)
Nov 21, 2022	2022 (Q3)	-0.17 / -0.47	-1.94	75.77% (+1.47)
Aug 16, 2022	2022 (Q2)	-0.06 / -0.45	-0.49	8.16% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed